Scholarlink

Objectives <p>To develop and validate a multi-task deep learning (MTDL) model using multiphase contrast-enhanced CT (CECT) for simultaneously assessing histological subtypes, clinical stages, and anatomical complexity grades of solid malignant renal tumors.</p> Materials and methods <p>This two-center retrospective study included patients with solid malignant renal tumors and their preoperative kidney CECT images. A progressive layered extraction (PLE)-based MTDL model was trained and externally tested. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA), compared with the results of five radiologists.</p> Results <p>Among 798 patients (mean age, 54 ± 12 years; 279 females; Center A: <i>n</i> = 620, Center B: <i>n</i> = 178), 597 (74.8%) had clear cell renal cell carcinomas (ccRCC), 150 (18.8%) were clinical staging III/IV, and 187 (23.4%) had high anatomical complexity. On the external test set, the MTDL model achieved AUCs of 0.89 (95% CI: 0.82, 0.94) for distinguishing ccRCC from non-ccRCC, 0.87 (95% CI: 0.81, 0.93) for clinical staging (I/II vs. III/IV), and 0.87 (95% CI: 0.82, 0.92) for anatomical complexity grading (low-intermediate vs. high). The MTDL model outperformed single-task deep learning (STDL) in clinical staging (AUC: 0.87 vs. 0.82, <i>p</i> = 0.022), showed higher net benefit on DCA, and demonstrated better diagnostic performance than junior radiologists in histological subtyping and clinical staging. Additionally, it used 68% less memory and was 60% faster than STDL models.</p> Conclusion <p>The CECT-based MTDL model demonstrated robust performance in simultaneously predicting histological subtypes, clinical stages, and anatomical complexity grades of malignant renal tumors.</p> Key Points <p><Emphasis Type="BoldItalic">Question</Emphasis> <i>Accurate preoperative description of the histological subtyping, clinical staging, and anatomical complexity of malignant renal tumors is crucial for treatment decision-making</i>.</p> <p><Emphasis Type="BoldItalic">Findings</Emphasis> <i>By sharing features, the multi-task deep learning algorithm model enhances clinical staging performance and significantly improves computational efficiency in predicting all three tasks simultaneously</i>.</p> <p><Emphasis Type="BoldItalic">Clinical relevance</Emphasis> <i>The multi-task deep learning algorithm model enables rapid and accurate comprehensive preoperative evaluation of renal tumors, which assists surgeons in optimizing surgical plans and promotes the advancement of renal tumor management toward precision and efficiency</i>.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A comprehensive multi-task deep learning model for kidney cancer: histological subtyping, clinical staging, and anatomical complexity grading

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月28日

查看全文
  • Dongqin Lv,
  • Renyi Liu,
  • Xiaochun Wang,
  • Tianli Liang,
  • Ling Zhang,
  • Weixiong Zeng,
  • Zilong He,
  • Limei Deng,
  • Zhi Zhang,
  • Genggeng Qin,
  • Weiguo Chen

摘要

Objectives

To develop and validate a multi-task deep learning (MTDL) model using multiphase contrast-enhanced CT (CECT) for simultaneously assessing histological subtypes, clinical stages, and anatomical complexity grades of solid malignant renal tumors.

Materials and methods

This two-center retrospective study included patients with solid malignant renal tumors and their preoperative kidney CECT images. A progressive layered extraction (PLE)-based MTDL model was trained and externally tested. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA), compared with the results of five radiologists.

Results

Among 798 patients (mean age, 54 ± 12 years; 279 females; Center A: n = 620, Center B: n = 178), 597 (74.8%) had clear cell renal cell carcinomas (ccRCC), 150 (18.8%) were clinical staging III/IV, and 187 (23.4%) had high anatomical complexity. On the external test set, the MTDL model achieved AUCs of 0.89 (95% CI: 0.82, 0.94) for distinguishing ccRCC from non-ccRCC, 0.87 (95% CI: 0.81, 0.93) for clinical staging (I/II vs. III/IV), and 0.87 (95% CI: 0.82, 0.92) for anatomical complexity grading (low-intermediate vs. high). The MTDL model outperformed single-task deep learning (STDL) in clinical staging (AUC: 0.87 vs. 0.82, p = 0.022), showed higher net benefit on DCA, and demonstrated better diagnostic performance than junior radiologists in histological subtyping and clinical staging. Additionally, it used 68% less memory and was 60% faster than STDL models.

Conclusion

The CECT-based MTDL model demonstrated robust performance in simultaneously predicting histological subtypes, clinical stages, and anatomical complexity grades of malignant renal tumors.

Key Points

Question Accurate preoperative description of the histological subtyping, clinical staging, and anatomical complexity of malignant renal tumors is crucial for treatment decision-making.

Findings By sharing features, the multi-task deep learning algorithm model enhances clinical staging performance and significantly improves computational efficiency in predicting all three tasks simultaneously.

Clinical relevance The multi-task deep learning algorithm model enables rapid and accurate comprehensive preoperative evaluation of renal tumors, which assists surgeons in optimizing surgical plans and promotes the advancement of renal tumor management toward precision and efficiency.

Graphical Abstract